Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.

Texas, on Wednesday published a 47-page report titled “The Case for Healthcare Freedom" as a roadmap to "Make American ...

Shares of Keros Therapeutics KROS, a clinical-stage biotech, have plunged 80.9% in the past three months. The massive decline was primarily due to the company’s voluntary decision to halt dosing in ...

The study, from the Kaohsiung Armed Forces General Hospital in Taiwan, contained 3,909 men with ED between 2010 and 2021.

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales. Pfizer has made progress, especially on the clinical and regulatory ...

Highlights,Eli Lilly achieved a 20.4% revenue growth year-over-year in Q3.,Earnings per share (EPS) fell below expectations ...

India equity was one of the top-performing markets in the APAC region, with its equity market advancing 13.3% in 2024, driven by solid domestic fundamentals and rising capex growth.

LAS VEGAS, NV / ACCESS Newswire / January 23, 2025 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical and transdermal pharmaceutical research and ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...